Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
This article compares index fund choices for retirement in 2024, focusing on S&P 500 vs Total Market performance and cost considerations.
24,938 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...
Taylor Swift and Travis Kelce announced a $26 million donation to 20 charities this week, fueling talk of a Friday Ma...
Brookstone Capital's 13F reveals a modest stake in the XRP ETF, but viral posts claim a $71 million position due to a...
Insider buying can reveal confidence that outsiders may miss. This guide breaks down how to read the signals, separat...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Investors are scanning for AI leaders beyond the obvious names. This article builds a case for why Broadcom could be ...
SpaceX's record IPO ignited a heated spacex wall street debating about AI spending and market risk. This piece breaks...
Microsoft stock has pulled back in a surprising turn for a tech giant. This article unpacks the reasons behind the dr...